162 related articles for article (PubMed ID: 34708280)
1. The optimal timing of radiotherapy in the combination treatment of limited-stage extranodal natural killer/T-cell lymphoma, nasal type: an updated meta-analysis.
Cui Y; Yao Y; Chen M; Jiang Y; Ren Q
Ann Hematol; 2021 Dec; 100(12):2889-2900. PubMed ID: 34708280
[TBL] [Abstract][Full Text] [Related]
2. The optimal timing of radiotherapy in the combined modality therapy for limited-stage extranodal NK/T cell lymphoma (ENKTL): a systematic review and meta-analysis.
Hu S; Zhou D; Zhang W
Ann Hematol; 2018 Dec; 97(12):2279-2287. PubMed ID: 30128904
[TBL] [Abstract][Full Text] [Related]
3. The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma.
Kim TH; Kim JS; Suh YG; Cho J; Yang WI; Suh CO
Yonsei Med J; 2016 Jul; 57(4):846-54. PubMed ID: 27189276
[TBL] [Abstract][Full Text] [Related]
4. Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Michot JM; Mazeron R; Danu A; Lazarovici J; Ghez D; Antosikova A; Willekens C; Chamseddine AN; Minard V; Dartigues P; Bosq J; Carde P; Koscielny S; De Botton S; Ferme C; Girinsky T; Ribrag V
Eur J Cancer; 2015 Nov; 51(16):2386-95. PubMed ID: 26254810
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of upfront concurrent chemoradiotherapy followed by P-GDP regimen in newly diagnosed early stage extranodal nasal-type NK/T cell lymphoma: A prospective single-center phase II study.
Zhu F; Liu T; Pan H; Xiao Y; Li Q; Liu X; Chen W; Wu G; Zhang L
Medicine (Baltimore); 2020 Aug; 99(33):e21705. PubMed ID: 32872045
[TBL] [Abstract][Full Text] [Related]
6. Pegaspargase Combined with Concurrent Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Two-Center Phase II Study.
Wang H; Wang L; Li C; Wuxiao Z; Chen G; Luo W; Lu Y
Oncologist; 2020 Nov; 25(11):e1725-e1731. PubMed ID: 32627928
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma.
Wei W; Wu P; Li L; Zhang ZH
Hematology; 2017 Jul; 22(6):320-329. PubMed ID: 27917702
[TBL] [Abstract][Full Text] [Related]
8. Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.
Kwong YL; Kim SJ; Tse E; Oh SY; Kwak JY; Eom HS; Do YR; Mun YC; Lee SR; Shin HJ; Suh C; Chuang SS; Lee YS; Lim ST; Izutsu K; Suzuki R; Relander T; d'Amore F; Schmitz N; Jaccard A; Kim WS
Ann Oncol; 2018 Jan; 29(1):256-263. PubMed ID: 29077846
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma.
Moon JH; Lee BH; Kim JA; Lee YJ; Chae YS; Yhim HY; Kwak JY; Do YR; Park Y; Song MK; Shin HJ; Kim T; Lee JJ; Yang DH
Leuk Res; 2016 Oct; 49():80-7. PubMed ID: 27608179
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcome of radiotherapy alone versus radiochemotherapy in IE/IIE extranodal nasal-type natural killer/T cell lymphoma: a meta-analysis.
Deng T; Zhang C; Zhang X; Wu S; Xu Y; Liu S; Chen X
PLoS One; 2014; 9(9):e106577. PubMed ID: 25184382
[TBL] [Abstract][Full Text] [Related]
11. Promising clinical outcomes of sequential and "Sandwich" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage I
Wang HY; Niu SQ; Yang YY; Li YY; Chen HB; Zhang YJ
Cancer Med; 2018 Dec; 7(12):5863-5869. PubMed ID: 30484966
[TBL] [Abstract][Full Text] [Related]
12. Upfront radiation is essential for high-risk early-stage extranodal NK/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era.
Qi F; Chen B; Wang J; Lin X; Qi S; Yang J; Zhou S; Wang S; Gui L; Fang H; Liu P; Song Y; Yang S; Li Y; Dong M
Leuk Lymphoma; 2019 Nov; 60(11):2679-2688. PubMed ID: 31298062
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma.
Yang CW; Wang CW; Hong RL; Tsai CL; Yao M; Tang JL; Lin CW; Cheng AL; Kuo SH
J Radiat Res; 2017 Jan; 58(1):114-122. PubMed ID: 27534792
[TBL] [Abstract][Full Text] [Related]
14. Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma.
Yang Y; Cao JZ; Lan SM; Wu JX; Wu T; Zhu SY; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Xu LM; Yuan ZY; Qi SN; Li YX
JAMA Oncol; 2017 Jan; 3(1):83-91. PubMed ID: 27893001
[TBL] [Abstract][Full Text] [Related]
15. "Sandwich" Chemotherapy (CT) with Radiotherapy (RT) improves outcomes in patients with stage IE/IIE extranodal natural killer (NK)/T-cell Lymphomas.
Zhang J; Zhu MY; Wang L; Wang H; Wang WD; Geng QR; Lu Y
Asian Pac J Cancer Prev; 2013; 14(7):4061-6. PubMed ID: 23991953
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experience.
Hattori Y; Murai T; Iwata H; Uchiyama K; Mimura M; Kato E; Murata R; Shibamoto Y
Jpn J Radiol; 2016 Apr; 34(4):292-9. PubMed ID: 26852128
[TBL] [Abstract][Full Text] [Related]
17. Appropriate timing to perform an interim
Wang R; Zhang Y; Fan Q; Jiang M; Zou L; Su M
Ann Hematol; 2024 Mar; 103(3):885-892. PubMed ID: 38030892
[TBL] [Abstract][Full Text] [Related]
18. Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience.
Zang J; Li C; Luo SQ; Wang JH; Xu M; Zhao LN; Li WW; Yang H; Xiao F; Hitchcock YJ; Shi M
Ann Hematol; 2015 Apr; 94(4):583-91. PubMed ID: 25409913
[TBL] [Abstract][Full Text] [Related]
19. Comparison of chemoradiotherapy with radiotherapy alone for early-stage extranodal natural killer/T-cell lymphoma, nasal type in elderly patients.
Su C; Nguyen KA; Bai HX; Balaji D; Cao Y; Karakousis G; Zhang PJ; Zhang G; Xiao R
Leuk Lymphoma; 2018 Jun; 59(6):1406-1412. PubMed ID: 28980517
[TBL] [Abstract][Full Text] [Related]
20. Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma: A multicenter study.
Zhang Y; Ma S; Cai J; Yang Y; Jing H; Shuang Y; Peng Z; Li B; Liu P; Xia Z; Xia Y; Gao Y; Chen D; Lin J; Li Q; Xu S; Xu Q; Zhang H; Huang H; Cai Q
Am J Hematol; 2021 Nov; 96(11):1481-1490. PubMed ID: 34449095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
